Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • tnorman61 tnorman61 Nov 24, 2013 3:52 PM Flag

    Based on 15,000 worldwide patients at $300,000

    the $300,000 figure is close, but the 15,000 is not.
    As a shareholder, I hope the company reaches that level
    in a timely manner.
    nt

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You challenge the 15,000 number based on ... your worldwide examination of actual diagnosis of HoFH patients? No wait, that is where the 15,000 number came from. If you don't believe in that number, then you must be using the theoretical projection from the probability model instead.

      What will you do when they find the mathematical error in the probability model? Arthur, you simply don't get it do you? The 15K number is based on REALITY. How many people ACTUALLY HAVE HoFH. Real patients diagnosed. Not some outdated guess.

      This is the same situation as breast cancer and many other diseases that were thought to have much lower incident rates before they had treatments. Then, when treatments were developed, the true patient count skyrocketed.

      Never mind, you'll never learn.

 
AEGR
5.71-0.47(-7.61%)Feb 12 3:59 PMEST